South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

janssen -

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - betamethasone valerate eqv betamethasone - cream - 0.025% w/w

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - 44757 - synovial fluid supplementation substance - a very highly purified viscoelastic, sterile solution of highly purified, high molecular weight (2.4-3.6 million daltons) hyaluronan (also known as sodium hyaluronate) in phosphate-buffered saline; extracted from bacterial cells. a polysaccharide consisting of a repeating disaccharide of n-acetylglucosamine and sodium glucuronate, linked by alternating b? 1,3 and b? 1,4 glycosidic bonds. euflexxa is indicated for the treatment of pain caused by osteoarthritis of the knee joint or other synovial joints. euflexxa aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Australia - English - Department of Health (Therapeutic Goods Administration)

surgical specialties pty ltd - 44757 - synovial fluid supplementation substance - monovisc? cross-linked sodium hyaluronate injection is a single, intra-articular injection of cross-linked sodium hyaluronate designed to treat the symptoms of osteoarthritis. the actions of monovisc? are lubrication and mechanical support. monovisc is indicated as a viscoelastic supplement or a replacement for synovial fluid in human knee joints. monovisc is well suited for treatment of the symptoms of mild to moderate osteoarthritis of the human knee joints for patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics.

Australia - English - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - 44757 - synovial fluid supplementation substance - durolane sj contains 20 mg/ml of stabilized non-animal hyaluronic acid in buffered physiological sodium chloride solution ph 7. durolane sj is presented in a 1ml glass syringe with a rigid cap and plunge stopper. the syringe is assembled with a luer-lock adapter, finger grip and plunger rod. durolane sj is injected into the synovial joint by an authorized person experienced in intraarticular injections following an aseptic technique using an 18 to 22 gauge needle (not supplied). intended to be used for intra-articular injection for symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, elbow, wrist, fingers, and toes. durolane sj is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within three months of the procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

surgical specialties pty ltd - 44757 - synovial fluid supplementation substance - cingal? is an off-white, opaque, sterile, single-use suspension of a cross-linked ha gel and an ancillary corticosteroid, th. cingal? is biocompatible and non-pyrogenic. the cross-linked ha and th in cingal? do not physically or chemically interact, as micronized particles of the th are suspended in the viscoelastic ha gel and reside in the product as a separate solid phase. cingal? is indicated as a viscoelastic supplement or a replacement for synovial fluid in the knee. cingal? is well suited for rapid and long term relief of the symptoms of knee joint dysfunctions such as osteoarthritis. the actions of cingal? are long term relief of symptoms by lubrication and mechanical support supplemented by short-term pain relief provided by triamcinolone hexacetonide.

Australia - English - Department of Health (Therapeutic Goods Administration)

bioinnova pty ltd - 44757 - synovial fluid supplementation substance - a sterile 1% sodium hyaluronate solution in prefilled glass syringe, with luer lock system for intra-articular use. single dose preparation for injection once per treatment course. adant is intended for intra-articular use to treat pain associated with osteoarthritis of the knee. adant improves articular mobility and normalises diseased synovia, thus relieving pain in the affected knee.